Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
O95445
UPID:
APOM_HUMAN
Alternative names:
Protein G3a
Alternative UPACC:
O95445; B0UX98; Q5SRP4; Q9P046; Q9UMP6
Background:
Apolipoprotein M, also known as Protein G3a, plays a crucial role in lipid transport. It has a unique ability to bind various lipids and retinoids, including sphingosine-1-phosphate, myristic acid, palmitic acid, stearic acid, retinol, all-trans-retinoic acid, and 9-cis-retinoic acid. This binding capacity suggests its involvement in multiple lipid signaling pathways and homeostasis.
Therapeutic significance:
Understanding the role of Apolipoprotein M could open doors to potential therapeutic strategies. Its capacity to interact with key lipid molecules positions it as a significant player in lipid metabolism and cardiovascular health. Exploring its functions further could lead to novel interventions for lipid-related disorders.